<i>RYK</i> Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients

Temozolomide (TMZ) chemotherapy is an important tool in the treatment of glioma brain tumors. However, variable patient response and chemo-resistance remain exceptionally challenging. Our previous genome-wide association study (GWAS) identified a suggestively significant association of SNP rs4470517...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ricardo D. Gonzalez, George W. Small, Adrian J. Green, Farida S. Akhtari, Tammy M. Havener, Julia C. F. Quintanilha, Amber B. Cipriani, David M. Reif, Howard L. McLeod, Alison A. Motsinger-Reif, Tim Wiltshire
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-05-01
coleção:	Pharmaceuticals
Assuntos:	GWAS chemotherapy sensitivity resistance glioma drug response
Acesso em linha:	https://www.mdpi.com/1424-8247/16/5/726
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!